The U.S. Food and Drug Administration says drug makers have recalled greater than a half-million bottles of the blood pressure treatment prazosin hydrochloride over issues it might embrace a cancer-causing chemical.
New Jersey-based Teva Pharmaceuticals USA and medicines distributor Amerisource Health Services issued voluntary nationwide recalls earlier this month of greater than 580,000 bottles of varied strengths of prazosin capsules, in response to the FDA.
Doctors prescribe prazosin, which relaxes blood vessels, to assist decrease blood pressure. It additionally is usually prescribed for nightmares and different sleep disturbances brought on by post-traumatic stress dysfunction.
The FDA stated in enforcement orders posted on-line that it has given the affected a lot of the drug a Class II danger classification as a result of a few of the recalled treatment could have nitrosamine impurities which might be thought of probably most cancers inflicting.
According to the FDA, N-nitrosamine impurities are a class of doubtless cancer-causing chemical compounds that may type throughout manufacture or storage of a drug.